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In recent years, cooling of the patient after cardiac 
arrest has become one of the basic procedures dur-
ing post-resuscitation care, which has been reflected 
in the guidelines of both the European Resuscitation 
Council and the American Heart Association. Tar-
geted temperature management (TTM), previously 
known as therapeutic hypothermia, is a procedure 
associated with controlled lowering of body temper-
ature to prevent tissue and organ damage and has 
well-established role in emergency medicine.
Currently, many techniques of lowering body tem-
perature are available, including surface cooling and 
invasive cooling. In patients with subarachnoid haem-
orrhage, treatment with intravenous cooling catheters 
reduces the risk of thrombotic complications such 
as pulmonary embolism and thrombosis. In a study 
by Pittl et al., the use of surface and invasive cool-
ing showed comparable effectiveness in lowering the 
patient temperature, but invasive cooling provided 
higher temperature stability, although it was also asso-
ciated with a higher incidence of bleeding. Both cool-
ing techniques were also associated with comparable 
survival to hospital discharge and comparable neuro-
logical status of patients. Regardless of the method 
of hypothermia induction, continuous measurements 
of core body temperature of the patient are essential 
and the temperature of the brain should not differ 
from the body temperature by more than 0.1–0.2 de-
grees  [1]. It is recommended that the temperature 
be measured in at least two different locations, in 
order to obtain accurate measurement results. Most 
commonly used are sensors placed in the oesophagus, 
urinary bladder or pulmonary artery.
In the induction phase, TTM may result in hypo-
volaemia, increased haematocrit, microcirculation 
disturbances, arrhythmias and electrolyte abnormal-
ities; therefore, the patient’s condition should be 
monitored and all abnormalities corrected. The main 
adverse effect during TTM induction is shivering. To 
avoid this complication, magnesium infusion can be 
used to maintain magnesium level above 2 mmol/L, 
as well as sedatives and, ultimately, the neuromus-
cular blocking agents. 
Current recommendations of the International 
Liaison Committee on Resuscitation and (ILCOR) 
and guidelines of both the European Resuscitation 
Council [2] and the American Cardiac Society [3] 
recommend the use of TTM in all comatose patients 
(≤ 8 pts) who experience return of spontaneous 
circulation (ROSC) following sudden cardiac arrest. 
Hypothermia within 32–36°C should be maintained 
for 24 hours and then continued for at least next 
24 hours. Polderman [4] in his study on an animal 
model has shown that the earlier the induction of 
therapeutic hypothermia, the faster the target tem-
perature is achieved, which translates into good 
neurological status. However, both randomized tri-
al by Bernard et al. [5] and meta-analysis by Diao 
et al. [6] have shown that immediate cooling of 
the patient at the scene of the accident had no 
effect on survival or improvement in neurological 
status. As shown in the RINSE-Trial performed by 
Bernard et al., the use of rapid infusion of cold saline 
during resuscitation of patients with defibrillation 
rhythm may reduce the rate of spontaneous cardi-
oversion  [7]. The therapeutic window for the use 
of TTM in patients after ROSC remains unknown. 
Currently, the protocols are based on the study by 
Bernard et al. and the Hypothermia after Cardiac Ar-
rest (HACA) group, according to which TTM should 
be implemented within 6 hours after the return of 
spontaneous circulation.
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Therapeutic hypothermia has been used both in 
patients with defibrillation [8] and non-defibrilla-
tion [9] rhythms. When compared with normother-
mia, TTM improves prognosis in adults after spon-
taneous cardioversion [2, 3], but not in outpatient 
[10, 11] or in-hospital [12] paediatric patients with 
cardiac arrest. Moreover, TTM should also be used 
in unconscious patients with cardiac arrest compli-
cated by myocardial infarction.
Mild to moderate hypothermia improves neu-
rological prognosis in neonates with hypoxic brain 
injury [12]. Newborns with moderate to severe hy-
poxic-ischaemic encephalopathy should be provided 
with therapeutic hypothermia. Jacobs et al. sug-
gested that TTM should be used in children born 
before 36 weeks of gestation. There are biological 
evidences indicating that TTM should be considered 
as a treatment option in premature infants [13]. 
Treatment should be in accordance with protocols 
used in randomized clinical trials: TTM should be 
initiated within 6 hours after birth and continued 
up to 72 hours after birth, with heating duration of 
at least 4 hours. Shankaran et al. have shown that 
whole-body hypothermia reduces the risk of death 
and disability in infants with moderate to severe 
hypoxic-ischaemic encephalopathy [12]. Therapeutic 
hypothermia is also associated with a decrease in sei-
zures after discharge from intensive care units [14].
Effective control of body temperature is one of 
the key components of the management of patients 
requiring intensive neurological care. Diringer et al. 
have demonstrated that elevated temperature in 
patients treated in the intensive care unit was associ-
ated with prolonged hospital stay, poorer prognosis 
and increased mortality [15]. Lowering the brain 
temperature by only 2–3 degrees in patients with 
acute cerebral ischaemia significantly reduces brain 
damage [16]. Therapeutic hypothermia in ischaemic 
stroke may potentially be effective in reducing brain 
oedema around the haematoma and improving 
treatment outcomes [17]. The authors of COOLAID 
and ICTUS-L studies have shown that TTM is an easy 
and safe procedure for patients with acute stroke, 
although associated with adverse effects (such as 
shivering, pneumonia and hypertension). Research-
ers involved in the COOLAID Oresund programme 
have concluded that the use of TTM in intensive care 
units provides better control of shivering and tem-
perature itself, and that the cooling of unconscious 
patients with stroke can be used to monitor their 
neurological status. Abdullah in the pilot study has 
also demonstrated the effectiveness of TTM in the 
management of haemorrhagic stroke [18].
Therapeutic hypothermia is used in adult patients 
after traumatic brain injury, improving neurologi-
cal status and reducing mortality. Meta-analysis by 
Crampton et al. [19] indicated that the optimal cool-
ing strategy in traumatic brain injury resulting in best 
protective effects on brain function should be based 
on cooling the brain and maintaining hypothermia 
for 72 hours. Studies have shown that the adminis-
tration of barbiturates may limit the benefits of TTM. 
Therapeutic hypothermia can be used in the man-
agement of traumatic brain injury in adults; however, 
it is not recommended for paediatric patients.
In conclusion, TTM is widely used to improve 
neurological outcomes and survival, but despite 
proven effectiveness it is still a rarely-used proce-
dure in Poland.
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